Search results for "EB"

showing 10 items of 15658 documents

Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2…

2019

Norursodeoxycholic acid is an orally administered side chain-shortened homologue of ursodeoxycholic acid that undergoes hepatic enrichment with hepatoprotective, anti-inflammatory, and antifibrotic activity. We assessed the efficacy of two doses of norursodeoxycholic acid versus placebo for the treatment of non-alcoholic fatty liver disease.We did a multicentre, double-blind, placebo-controlled, randomised, phase 2 dose-finding clinical trial in tertiary referral hospitals and medical centres in Austria (n=6) and Germany (n=23) for patients with non-alcoholic fatty liver disease with or without diabetes. Patients with a clinical diagnosis of non-alcoholic fatty liver disease and serum alani…

AdultBlood GlucoseMalemedicine.medical_specialtyCholagogues and CholereticsPopulationPlaceboGastroenterologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialDouble-Blind MethodlawNon-alcoholic Fatty Liver DiseaseDiabetes mellitusInternal medicinemedicineHumansAspartate Aminotransferaseseducationeducation.field_of_studyHepatologyDose-Response Relationship Drugbusiness.industryFatty liverUrsodeoxycholic AcidGastroenterologyAlanine TransaminaseMiddle Agedmedicine.diseaseLipidsUrsodeoxycholic acidClinical trialDose–response relationshipTreatment Outcome030220 oncology & carcinogenesis030211 gastroenterology & hepatologyFemalebusinessmedicine.drugThe lancet. Gastroenterologyhepatology
researchProduct

A single acute dose of pinitol from a naturally-occurring food ingredient decreases hyperglycaemia and circulating insulin levels in healthy subjects.

2013

A limited amount of research suggests that oral ingestion of pinitol (3-O-methyl-d-chiro-inositol) positively influences glucose tolerance in humans. This study assessed the effects of different doses of pinitol supplementation on glucose tolerance, insulin sensitivity and plasma pinitol concentrations. Thirty healthy subjects underwent two one-day trials in which they consumed a nutritive beverage (Fruit Up®) containing 2.5, 4.0 or 6.0g of pinitol and a corresponding placebo equivalent in both energy and carbohydrates. Blood samples were collected frequently over the 240-min test period. The pinitol-enriched beverage reduced serum glucose and insulin at 45 and 60min, but only at a dose of …

AdultBlood GlucoseMalemedicine.medical_specialtymedicine.medical_treatmentBlood sugarDown-RegulationPlaceboAnalytical ChemistryBeverageschemistry.chemical_compoundIngredientBlood serumInternal medicinemedicineIngestionHumansInsulinPinitolbusiness.industryInsulinGeneral MedicineEndocrinologychemistryBlood chemistryHyperglycemiaFemalebusinessInositolFood Science
researchProduct

Effects of gemfibrozil on insulin sensitivity and on haemostatic variables in hypertriglyceridemic patients.

2000

In order to assess the efficacy of gemfibrozil on lipid and haemostatic parameters in patients with plurimetabolic syndrome, a multicenter double-blind placebo controlled, parallel study was carried out in 56 patients with primary hypertriglyceridemia and glucose intolerance. These patients had elevated PAI activity and antigen and t-PA antigen levels at rest and after venous occlusion. Gemfibrozil reduced plasma triglyceride levels (P0.001), whereas it increased free fatty acids (P0.05) and high density lipoprotein cholesterol levels (P0.05). In those patients reaching normalization of plasma triglyceride levels (triglyceride reductionor =50%) (n=15), insulin levels (P0.05) as well as the …

AdultBlood GlucoseMalemedicine.medical_specialtymedicine.medical_treatmentFatty Acids NonesterifiedPlaceboFibrinogenInsulin resistanceDouble-Blind MethodInternal medicinemedicineGemfibrozilHumansInsulinAgedHypolipidemic AgentsHypertriglyceridemiaHemostasisbusiness.industryT-plasminogen activatorInsulinHypertriglyceridemiaParallel studyGlucose Tolerance TestMiddle Agedmedicine.diseaseEndocrinologyGemfibrozilInsulin ResistanceCardiology and Cardiovascular Medicinebusinessmedicine.drugAtherosclerosis
researchProduct

Serum Concentration of Growth Differentiation Factor-15 Is Independently Associated with Global Platelet Function and Higher Fibrinogen Values in Adu…

2017

AbstractGrowth differentiation factor-15 (GDF-15) has recently emerged as a strong and independent predictor of cardiovascular events and mortality. However, the pathophysiological mechanisms underlying this important association remain speculative. This study was aimed to investigate the potential associations between the serum concentration of GDF-15 and clinical or laboratory parameters in a population of ostensibly healthy subjects. The study population consisted of 44 healthy volunteers enrolled from the laboratory staff (14 males and 30 females; mean age, 47 ± 11 years), who had their blood collected for assessing complete blood cell count, GDF-15, serum creatinine, albumin, cardiac t…

AdultBlood PlateletsMalemedicine.medical_specialtyGrowth Differentiation Factor 15Platelet Function TestsPopulationRenal function030204 cardiovascular system & hematologyFibrinogenGrowth Differentiation Factor-15 Platelet Function Fibrinogen03 medical and health scienceschemistry.chemical_compound0302 clinical medicineVon Willebrand factorInternal medicinemedicineHumansPlatelet030212 general & internal medicineeducationGrowth Differentiation Factor-15Analysis of VarianceCreatinineeducation.field_of_studybiologybusiness.industryPlatelet FunctionFibrinogenHematologyMiddle AgedHealthy VolunteersEndocrinologychemistryembryonic structuresLinear Modelsbiology.proteinPopulation studyFemaleGDF15Cardiology and Cardiovascular Medicinebusinessmedicine.drugSeminars in Thrombosis and Hemostasis
researchProduct

Thalamic infarctions cause side-specific suppression of vestibular cortex activations.

2005

H2O15-PET was performed during caloric vestibular stimulation of the right and left external ears in eight right-handed patients with acute unilateral infarctions or haemorrhages of the posterolateral thalamus (four right, four left). The posterolateral thalamus is the relay station for ipsi- and contralateral ascending vestibular input to the multiple multisensory vestibular cortex areas. The aim of this study was to evaluate the differential effects of unilateral vestibular thalamic lesions on thalamo-cortical projections, right hemispheric dominance and reciprocal inhibitory visual-vestibular interaction, as well as perceptual and ocular motor consequences during caloric irrigation. The …

AdultBrain InfarctionMaleEye MovementsThalamusMotion PerceptionSensory systemVestibular nucleiThalamusCortex (anatomy)otorhinolaryngologic diseasesmedicineCaloric TestsImage Processing Computer-AssistedPsychophysicsHumansInner earDominance CerebralAgedVestibular systemCerebral CortexBrain MappingAnatomyMiddle AgedVestibular cortexElectrooculographymedicine.anatomical_structureVestibulePositron-Emission TomographyFemalesense organsNeurology (clinical)Vestibule LabyrinthPsychologyNeuroscienceBrain : a journal of neurology
researchProduct

Dysarthria in acute ischemic stroke: lesion topography, clinicoradiologic correlation, and etiology.

2001

Background and purpose: Although dysarthria is a frequent symptom in cerebral ischemia, there is little information on its anatomic specificity, spectrum of associated clinical characteristics, and etiologic mechanisms. Methods: An investigation of 68 consecutive patients with sudden onset of dysarthria due to a single infarction confirmed by MRI or CT was conducted. Results: Dysarthria was associated with a classic lacunar stroke syndrome in 52.9% of patients. Isolated dysarthria and dysarthria–central facial and lingual paresis occurred in 2.9% (n = 2) and 10.3% (n = 7), respectively. Dysarthria–clumsy hand syndrome was observed in 11.7% (n = 8) of patients and associated with pure motor …

AdultBrain InfarctionMalePathologymedicine.medical_specialtyLacunar strokeInternal capsuleBrain IschemiaDysarthriaInternal Capsulemedicine.arteryInternal medicineCerebellumCentrum semiovalemedicineHumansSuperior cerebellar arteryAgedRetrospective StudiesAged 80 and overChi-Square Distributionbusiness.industryCerebral infarctionCerebral peduncleDysarthriaMiddle Agedmedicine.diseasenervous system diseasesHemiparesisIschemic Attack TransientCardiologyFemaleNeurology (clinical)medicine.symptombusinessNeurology
researchProduct

Anatomical correlates of ocular motor deficits in cerebellar lesions

2009

Humans are able to stabilize the images of moving targets on the retina by means of smooth pursuit eye movements. After the pontine level, all smooth pursuit pathways pass through the cerebellum. Previous animal studies gave evidence that two specific lesion sites within the cerebellum cause smooth pursuit disorders: those of the flocculus/paraflocculus and the vermis including lobule VI, VII, the uvula and the deep cerebellar nuclei. To date, there have been only a few lesion studies in patients with smooth pursuit disorders that do not allow direct comparison with a control group. In the present study, new lesion mapping techniques determined which cerebellar structures were involved in p…

AdultBrain InfarctionMalegenetic structuresFlocculusSmooth pursuitOcular Motility DisordersCerebellumHumansAgedAged 80 and overBrain MappingEye movementReflex Vestibulo-OcularOptokinetic reflexAnatomyMiddle AgedPursuit SmoothElectrooculographyAcute DiseaseFixation (visual)Cerebellar vermisReflexFemalesense organsNeurology (clinical)Vestibulo–ocular reflexPsychologyNeuroscienceBrain
researchProduct

Different generators in human temporal-parasylvian cortex account for subdural laser-evoked potentials, auditory-evoked potentials, and event-related…

2000

In order to localize cortical areas mediating pain we now report subdural cortical potentials evoked by auditory stimulation (auditory-evoked potentials - AEPs) and by cutaneous stimulation with a laser (laser-evoked potentials - LEPs). Stimulation with the laser evokes a pure pain sensation by selective activation of nociceptors. LEPs were maximal over the inferior aspect of the central sulcus and had the same polarity on either side of the sylvian fissure. AEPs were maximal posterior to the LEP maximum and had opposite polarity on opposite sides of the sylvian fissure, consistent with the location of a known generator in the temporal operculum. Auditory P3 (event-related) potentials were …

AdultBrain MappingLaser-Evoked PotentialsSecondary somatosensory cortexLasersGeneral NeuroscienceNociceptorsSomatosensory CortexSubdural SpaceAnatomyCentral sulcusTemporal LobeTemporal lobeElectrophysiologymedicine.anatomical_structureCerebral cortexEvoked Potentials SomatosensoryCortex (anatomy)Evoked Potentials AuditorymedicineHumansPsychologyOperculum (brain)Evoked PotentialsNeuroscienceNeuroscience Letters
researchProduct

Inhibition of dextromethorphan metabolism by moclobemide.

1998

This pilot study was conducted to evaluate the potential of the new antidepressant moclobemide to inhibit the cytochrome enzyme P4502D6 (CYP2D6) using the cough suppressant dextromethorphan as a substrate in four extensive metabolizers (EM) of debrisoquine. The subjects received seven oral doses of 20 mg dextromethorphan at 4-h intervals over 2 days (1 and 2) and subsequently moclobemide (300 mg b.i.d.) for 9 days. On days 10 and 11, they received seven doses of 20 mg dextromethorphan in addition to moclobemide. During monotreatment and combined treatment, blood was collected on days 2 and 11, respectively, for determination of dextromethorphan and its demethylated metabolites using automat…

AdultCYP2D6animal structuresMonoamine Oxidase InhibitorsAdolescentMoclobemidePharmacologyDextromethorphanchemistry.chemical_compoundPharmacokineticsOral administrationDextrorphanMoclobemideMedicineHumansDrug InteractionsBiotransformationPharmacologybusiness.industryDextromethorphanDrug interactionAntidepressive AgentsDebrisoquinechemistryArea Under CurveBenzamidesbusinessmedicine.drugPsychopharmacology
researchProduct

RCBF-quantification with 99mTc-HMPAO-SPECT: theory and first results.

1989

The activity concentrations of 99mTc-HMPAO in brain after intravenous injection were evaluated in 25 patients using SPECT. With additional first pass studies of heart and brain with the short lived isotope 195mAu, the cardiac output and the mean cerebral transit times of the patients were measured a short time before the HMPAO injection. The time dependence of 99mTc-HMPAO activity in the brain was registered during the first 5 min after injection over both hemispheres. Using a simplified three compartment model it was possible to calculate the mean retention fraction of HMPAO in brain from the time activity curves. It could be shown that the regional cerebral blood flow in ml/min per 100 g …

AdultCardiac outputCorrelation coefficientAdolescentHemodynamicsGrey matterTechnetium Tc 99m ExametazimeOximesmedicineOrganometallic CompoundsHumansRadiology Nuclear Medicine and imagingChild99mtc hmpao spectAgedmedicine.diagnostic_testbusiness.industryBrainTechnetiumGeneral MedicineMiddle Agedmedicine.anatomical_structureCerebral blood flowPositron emission tomographyCerebrovascular CirculationbusinessNuclear medicineTechnetium-99mTomography Emission-ComputedEuropean journal of nuclear medicine
researchProduct